CME Group (CME) Receiving Somewhat Favorable Media Coverage, Report Finds

News stories about CME Group (NASDAQ:CME) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CME Group earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned media stories about the financial services provider an impact score of 46.8314998467874 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the news articles that may have effected Accern Sentiment’s rankings:

Shares of CME Group (NASDAQ:CME) traded up $1.25 during trading hours on Friday, hitting $150.79. The stock had a trading volume of 2,805,896 shares, compared to its average volume of 1,097,660. CME Group has a 52-week low of $113.27 and a 52-week high of $152.14. The company has a market capitalization of $51,135.15, a PE ratio of 31.55, a P/E/G ratio of 3.10 and a beta of 0.72. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. CME Group’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $1.05 earnings per share. research analysts expect that CME Group will post 4.78 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 annualized dividend and a dividend yield of 1.75%. CME Group’s payout ratio is presently 59.86%.

CME has been the topic of a number of research reports. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 27th. Barclays raised their price objective on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th. UBS reaffirmed a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Royal Bank Of Canada raised their price objective on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 price objective on shares of CME Group in a research note on Friday, August 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company. CME Group has a consensus rating of “Buy” and an average target price of $141.75.

In related news, Director Dennis Suskind sold 750 shares of the firm’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $129.34, for a total value of $97,005.00. Following the sale, the director now directly owns 5,059 shares of the company’s stock, valued at $654,331.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey M. Bernacchi sold 1,501 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $149.75, for a total value of $224,774.75. Following the completion of the sale, the director now directly owns 60,194 shares in the company, valued at $9,014,051.50. The disclosure for this sale can be found here. Insiders sold 27,510 shares of company stock worth $3,889,604 over the last three months. 0.57% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This article was posted by Community Financial News and is owned by of Community Financial News. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.com-unik.info/2017/12/03/cme-group-cme-receiving-somewhat-favorable-media-coverage-report-finds.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

What are top analysts saying about CME Group Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit